Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lo.Li. Pharma is an Italian pharmaceutical company based in Rome that specializes in the development of medical devices and functional dietary supplements. Founded in 2001 by Vittorio Unfer, the company has gained international recognition for its pioneering research into inositols, particularly myo-inositol and D-chiro-inositol. Their product portfolio primarily addresses needs in gynecology, obstetrics, and urology, with flagship brands like Inofolic and Andrositol targeting polycystic ovary syndrome and male infertility. Lo.Li. Pharma maintains a strong commitment to scientific validation, collaborating with the Experts Group on Inositol in Basic and Clinical Research (EGOI) to produce extensive clinical data. The company operates globally, distributing its specialized health solutions to over 60 countries through a network of international partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lo.Li. Pharma.